Join
Live feed
·
PRReleasevia Quantisnow
Agenus Inc. logo
MiNK Therapeutics Inc. logo

Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer

ByQuantisnow·Wall Street's wire, on your screen.
AGEN· Agenus Inc.INKT· MiNK Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGEN (Agenus Inc.), INKT (MiNK Therapeutics Inc.) and more on Quantisnow.